Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Senti Biosciences (SNTI)

Senti Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNTI
DateTimeSourceHeadlineSymbolCompany
29/05/202421:14Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SNTISenti Biosciences Inc
29/05/202421:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNTISenti Biosciences Inc
29/05/202421:07Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNTISenti Biosciences Inc
17/05/202422:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNTISenti Biosciences Inc
17/05/202422:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNTISenti Biosciences Inc
13/05/202413:15GlobeNewswire Inc.Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
09/05/202421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNTISenti Biosciences Inc
09/05/202421:05GlobeNewswire Inc.Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate HighlightsNASDAQ:SNTISenti Biosciences Inc
30/04/202413:05GlobeNewswire Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)NASDAQ:SNTISenti Biosciences Inc
21/03/202420:05GlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
05/01/202421:05GlobeNewswire Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical ProgramNASDAQ:SNTISenti Biosciences Inc
22/12/202311:30GlobeNewswire Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
13/11/202321:15GlobeNewswire Inc.Senti Bio Announces Third Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
06/11/202321:05GlobeNewswire Inc.Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in ChinaNASDAQ:SNTISenti Biosciences Inc
31/10/202313:06GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual MeetingNASDAQ:SNTISenti Biosciences Inc
27/09/202314:05GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 MeetingNASDAQ:SNTISenti Biosciences Inc
26/09/202321:05GlobeNewswire Inc.Senti Bio to Participate in Upcoming ConferencesNASDAQ:SNTISenti Biosciences Inc
05/09/202313:30GlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
11/08/202313:35GlobeNewswire Inc.Senti Bio Announces Second Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
10/08/202313:35GlobeNewswire Inc.Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon PartnersNASDAQ:SNTISenti Biosciences Inc
20/05/202313:05GlobeNewswire Inc.Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:SNTISenti Biosciences Inc
09/05/202321:05GlobeNewswire Inc.Senti Bio Announces First Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
02/05/202321:45GlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual MeetingNASDAQ:SNTISenti Biosciences Inc
17/04/202313:45GlobeNewswire Inc.Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
14/04/202314:00GlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
22/03/202321:09GlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
14/03/202320:35GlobeNewswire Inc.Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
03/02/202321:05GlobeNewswire Inc.Senti Biosciences Announces New Employment Inducement GrantsNASDAQ:SNTISenti Biosciences Inc
01/02/202321:05GlobeNewswire Inc.Senti Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:SNTISenti Biosciences Inc
27/01/202313:00GlobeNewswire Inc.Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway GuidanceNASDAQ:SNTISenti Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SNTI

Your Recent History

Delayed Upgrade Clock